WGRF
WGRF (96.9 FM) is a commercial radio station in Buffalo, New York, branded as "97 Rock". The station is owned by Cumulus Media and broadcasts a classic rock radio format, mostly from the 1970s and 1980s. WGRF competes for classic rock listeners with cross-border rival 91.7 CIXL-FM. The studios are on Buffalo's East Side.WGRF has an effective radiated power of 24,000 watts. The transmitter is off Elmwood Avenue in Buffalo. It uses a directional antenna to protect CHYM-FM in Kitchener, Ontario, which is on 96.7 MHz. Provided by Wikipedia
Showing 1 - 13 results of 13 for search 'Larry Norton', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma by Willard Wong, Edi Brogi, Jorge S. Reis-Filho, George Plitas, Mark Robson, Larry Norton, Monica Morrow, Hannah Y. Wen
Published 2021-07-01
Article -
6
-
7
-
8
Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival by Anish K. Simhal, Kylee H. Maclachlan, Rena Elkin, Jiening Zhu, Larry Norton, Joseph O. Deasy, Jung Hun Oh, Saad Z. Usmani, Allen Tannenbaum
Published 2023-11-01
Article -
9
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer by Elizabeth Comen, Sadna Budhu, Yuval Elhanati, David Page, Teresa Rasalan-Ho, Erika Ritter, Phillip Wong, George Plitas, Sujata Patil, Edi Brogi, Maxine Jochelson, Yolanda Bryce, Stephen B. Solomon, Larry Norton, Taha Merghoub, Heather L. McArthur
Published 2024-02-01
Article -
10
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab by Emanuela Ferraro, Jasmeet Singh, Sujata Patil, Pedram Razavi, Shanu Modi, Sarat Chandarlapaty, Andrea V. Barrio, Rachna Malani, Ingo K. Mellinghoff, Adrienne Boire, Hannah Y. Wen, Edi Brogi, Andrew D. Seidman, Larry Norton, Mark E. Robson, Chau T. Dang
Published 2022-03-01
Article -
11
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases by David B. Page, Kathryn Beal, Stefanie N. Linch, Kateri J. Spinelli, Micaela Rodine, Darragh Halpenny, Shanu Modi, Sujata Patil, Robert J. Young, Thomas Kaley, Taha Merghoub, David Redmond, Phillip Wong, Christopher A. Barker, Adi Diab, Larry Norton, Heather L. McArthur
Published 2022-04-01
Article -
12
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer by Edaise M. da Silva, Pier Selenica, Mahsa Vahdatinia, Fresia Pareja, Arnaud Da Cruz Paula, Lorenzo Ferrando, Andrea M. Gazzo, Higinio Dopeso, Dara S. Ross, Ariya Bakhteri, Nadeem Riaz, Sarat Chandarlapaty, Pedram Razavi, Larry Norton, Hannah Y. Wen, Edi Brogi, Britta Weigelt, Hong Zhang, Jorge S. Reis-Filho
Published 2021-04-01
Article -
13
Anti-tumor effects of an ID antagonist with no observed acquired resistance by Paulina M. Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang, Bina Desai, Yvette Chin, Riddhi Shah, Sijia Xu, Saurabh Yadav, Sergey Yaklichkin, Ouathek Ouerfelli, Rajesh Kumar Soni, John Philip, David C. Montrose, John H. Healey, Vinagolu K. Rajasekhar, William A. Garland, Jeremy Ratiu, Yuan Zhuang, Larry Norton, Neal Rosen, Ronald C. Hendrickson, Xi Kathy Zhou, Antonio Iavarone, Joan Massague, Andrew J. Dannenberg, Anna Lasorella, Robert Benezra
Published 2021-05-01
Article